Pierre Geborek

affiliated with the university
More filtering options
  1. 2005
  2. Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept

    N Feltelius, CM Fored, P Blomqvist, L Bertilsson, Pierre Geborek, Lennart Jacobsson, S Lindblad, J Lysholm, S Rantapaa-Dahlqvist, Tore Saxne & L Klareskog, 2005, In : Annals of the Rheumatic Diseases. 64, 2, p. 246-252

    Research output: Contribution to journalArticle

  3. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

    J Askling, CM Fored, L Brandt, E Baecklund, L Bertilsson, L Coster, Pierre Geborek, Lennart Jacobsson, S Lindblad, J Lysholm, S Rantapaa-Dahlqvist, Tore Saxne, V Romanus, L Klareskog & N Feltelius, 2005, In : Arthritis and Rheumatism. 52, 7, p. 1986-1992

    Research output: Contribution to journalArticle

  4. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

    J Askling, CM Fored, L Brandt, E Baecklund, L Bertilsson, N Feltelus, L Coster, Pierre Geborek, LT Jacobsson, S Lindblad, J Lysholm, S Rantapaa-Dahlqvist, Tore Saxne & L Klareskog, 2005, In : Annals of the Rheumatic Diseases. 64, 10, p. 1421-1426

    Research output: Contribution to journalArticle

  5. 2004
  6. 2003
  7. 2002
  8. 2001
  9. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

    Agneta Scheja, Anita Åkesson, Pierre Geborek, Marie Wildt, Claes B Wollheim, Frank Wollheim & Ulrich M Vischer, 2001, In : Arthritis Research & Therapy. 3, 3, p. 178-182

    Research output: Contribution to journalArticle

  10. 2000
  11. Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis

    Pierre Geborek & Tore Saxne, 2000, In : Rheumatology. 39, 10, p. 1159-1161

    Research output: Contribution to journalArticle

  12. 1997
  13. 1995
  14. Hip involvement in early rheumatoid arthritis

    Kerstin Eberhardt, Eva Fex, Kjell Johnsson & Pierre Geborek, 1995, In : Annals of the Rheumatic Diseases. 54, 1, p. 45-48

    Research output: Contribution to journalArticle

  15. 1994
  16. Prevention of joint destruction in antigen-induced arthritis

    Frank Wollheim, Hans Telhag, Anders Henricsson & Pierre Geborek, 1994, In : Clinical Immunology and Immunopathology. 70, 1, p. 19-21

    Research output: Contribution to journalArticle

  17. 1993
  18. 1992
  19. 1991
  20. 1990
  21. IgM-ANCA in a patient with systemic vasculitis without pulmonary involvement

    L Nässberger & Pierre Geborek, 1990, In : Clinical Nephrology. 34, 6, p. 280-280

    Research output: Contribution to journalArticle

  22. MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA

    Ann G Björkengren, Pierre Geborek, Urban Rydholm, Stig Holtås & Holger Petterson, 1990, In : American Journal of Roentgenology: diagnostic imaging and related sciences . 155, 2, p. 329-332

    Research output: Contribution to journalArticle

  23. 1989
  24. 1988
  25. Measurement of oxygen and carbon dioxide partial pressures in synovial fluid after tonometry

    Pierre Geborek, B Lindoff & Sven Valind, 1988, In : Clinical Physiology. 8, 4, p. 427-432

    Research output: Contribution to journalArticle

  26. Mononuclear cells recovered from inflammatory synovial membrane using fine-needle biopsy

    Pierre Geborek, Magnhild Sandberg Wollheim & Frank Wollheim, 1988, In : Rheumatology International. 8, 3, p. 101-105

    Research output: Contribution to journalArticle

  27. 1987
  28. 1984
  29. Acute alveolitis and sulphasalazine in rheumatoid arthritis

    Pierre Geborek, M Monti, F Sandblad & Frank Wollheim, 1984, In : Clinical and Experimental Rheumatology. 2, 3, p. 279-280

    Research output: Contribution to journalArticle

Previous 1 2 3 Next